+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Small-Molecule APIs Market by Type, Production, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532977
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Small-Molecule APIs Market grew from USD 184.32 billion in 2023 to USD 197.35 billion in 2024. It is expected to continue growing at a CAGR of 7.26%, reaching USD 301.19 billion by 2030.

Small-molecule Active Pharmaceutical Ingredients (APIs) are organic compounds with low molecular weight that are pivotal in the formulation of various pharmaceutical drugs. These molecules can enter cells easily due to their small size, influencing targeted biological processes, such as enzyme interactions or cellular signaling. The necessity for small-molecule APIs primarily stems from their critical role in drug development across therapeutic areas like oncology, cardiology, and infectious diseases. They serve as the foundation of numerous medications, being significant in both generic and branded drug markets. With a wide range of applications and end-use in clinical therapeutics, the demand for small-molecule APIs continues to grow, driven by the global surge in chronic diseases and the consequent need for novel therapeutics. Technological advancements in manufacturing processes and the rise of contract manufacturing organizations (CMOs) as cost-efficient solutions further bolster market expansion. Additionally, the expiration of patents for blockbuster drugs opens lucrative opportunities for generic drug production using small-molecule APIs.

Nevertheless, the market faces challenges, such as stringent regulatory landscapes, high production costs, and the complexities involved in API synthesis. Moreover, issues like drug recalls due to quality failures can pose significant setbacks. To overcome these challenges, innovation in green chemistry, development of novel synthesis pathways, and enhancement of quality assurance techniques are promising areas for research and business growth. Market players should focus on collaborations and strategic partnerships to enhance R&D efforts and to expand their production capabilities globally. Despite the competition from biologics, small-molecule APIs hold substantial opportunities, particularly in developing personalized medicine and targeted drug delivery systems. As regulatory frameworks evolve to become more accommodating for advanced manufacturing techniques, companies that invest in smart, adaptive manufacturing processes are likely to maintain a competitive edge. Overall, in-depth understanding of market dynamics, coupled with strategic investment in innovation, will help stakeholders navigate the complex landscape of small-molecule APIs successfully.

Understanding Market Dynamics in the Small-Molecule APIs Market

The Small-Molecule APIs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of chronic diseases coupled with increasing geriatric population globally
    • Rising demand for generic drugs worldwide
  • Market Restraints
    • High cost associated with small-molecule APIs
  • Market Opportunities
    • Ongoing advancements in drug discovery and development
    • Collaborations with bio-pharmaceutical companies for combination therapies
  • Market Challenges
    • Stringent regulatory requirements for drug development

Exploring Porter’s Five Forces for the Small-Molecule APIs Market

Porter’s Five Forces framework further strengthens the insights of the Small-Molecule APIs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Small-Molecule APIs Market

External macro-environmental factors deeply influence the performance of the Small-Molecule APIs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Small-Molecule APIs Market

The Small-Molecule APIs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Small-Molecule APIs Market

The Small-Molecule APIs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Small-Molecule APIs Market

The Small-Molecule APIs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Biological
    • Synthetic
  • Production
    • Contract Manufacturing
    • In-House Manufacturing
  • Application
    • Cardiovascular
    • Diabetes
    • Immunological Disorders
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
5.1.1.2. Rising demand for generic drugs worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with small-molecule APIs
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in drug discovery and development
5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for drug development
5.2. Market Segmentation Analysis
5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Small-Molecule APIs Market, by Type
6.1. Introduction
6.2. Biological
6.3. Synthetic
7. Small-Molecule APIs Market, by Production
7.1. Introduction
7.2. Contract Manufacturing
7.3. In-House Manufacturing
8. Small-Molecule APIs Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.3. Diabetes
8.4. Immunological Disorders
8.5. Oncology
9. Americas Small-Molecule APIs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Small-Molecule APIs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Small-Molecule APIs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
12.3.2. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
12.3.3. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 52. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 53. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 59. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 86. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 87. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 92. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 93. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 105. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 141. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 161. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 167. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 173. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 179. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 185. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 196. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 197. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 215. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 220. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 221. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 226. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 227. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 251. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 269. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Small-Molecule APIs market, which are profiled in this report, include:
  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Alacrita Holdings Limited
  • Albemarle Corporation
  • Aspen Group
  • Astrazeneca PLC
  • Aurobindo Pharma Limited
  • Bachem Holding AG
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Cambrex Corporation by Permira funds
  • Carlyle Group
  • Charles River Laboratories International, Inc.
  • Deciphera Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd,
  • Gilead Sciences, Inc
  • GlaxoSmithKline PLC
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Merck KGaA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information